Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy
- PMID: 8411102
Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy
Abstract
Macaques were immunised with lentil lectin purified recombinant SIVmac (BK28) derived gp160 (rgp160) with or without live vaccinia (vac)-env (BK28) priming, followed by a final boost with solid matrix antibody antigen (SMAA)-gp160 (J5) complexes and challenged with the SIVmac molecularly cloned virus J5M. Rgp160 and vac-env plus gp160 induced strong Ab responses against the homologous virus. Live vac-env did not enhance or prolong the antibody response, however, T cell responses were stronger. Analysis of the specificity of the immune response demonstrated that sequence variation within SIVmac viruses can affect antibody and T cell recognition. A single booster immunisation with the heterologous SIVmac J5 env recombinant protein was not sufficient to protect against the molecularly cloned virus J5M. These findings further illustrate the difficulty of generating protective immunity with immunogens based on single sequence recombinants.
Similar articles
-
Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.J Med Primatol. 1992 Feb-May;21(2-3):50-8. J Med Primatol. 1992. PMID: 1433267
-
Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.J Med Primatol. 1993 Feb-May;22(2-3):92-9. J Med Primatol. 1993. PMID: 8411113
-
Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S27-32. AIDS Res Hum Retroviruses. 1994. PMID: 7865316
-
Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.Semin Immunol. 1993 Jun;5(3):215-23. doi: 10.1006/smim.1993.1025. Semin Immunol. 1993. PMID: 8394161 Review.
-
The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey.Curr Top Microbiol Immunol. 1994;188:175-84. doi: 10.1007/978-3-642-78536-8_10. Curr Top Microbiol Immunol. 1994. PMID: 7924426 Review. No abstract available.
Cited by
-
Identification of highly attenuated mutants of simian immunodeficiency virus.J Virol. 1998 Feb;72(2):1431-7. doi: 10.1128/JVI.72.2.1431-1437.1998. J Virol. 1998. PMID: 9445045 Free PMC article.
-
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.J Virol. 1996 Jun;70(6):3724-33. doi: 10.1128/JVI.70.6.3724-3733.1996. J Virol. 1996. PMID: 8648707 Free PMC article.